Call in the backup

Nat Med. 2012 Nov;18(11):1602-6. doi: 10.1038/nm1112-1602.
No abstract available

Publication types

  • News

MeSH terms

  • Clinical Trials as Topic*
  • Drug Industry
  • Gene Dosage
  • Genome, Human
  • Heterozygote
  • Histone Deacetylase Inhibitors / therapeutic use
  • Histone Deacetylases / administration & dosage
  • Humans
  • Infant, Newborn
  • Molecular Targeted Therapy
  • Motor Neurons / drug effects
  • Motor Neurons / metabolism*
  • Muscular Atrophy, Spinal / drug therapy*
  • Mutation
  • Survival of Motor Neuron 1 Protein / genetics*
  • Survival of Motor Neuron 1 Protein / therapeutic use
  • Survival of Motor Neuron 2 Protein / genetics
  • Survival of Motor Neuron 2 Protein / therapeutic use

Substances

  • Histone Deacetylase Inhibitors
  • SMN1 protein, human
  • SMN2 protein, human
  • Survival of Motor Neuron 1 Protein
  • Survival of Motor Neuron 2 Protein
  • Histone Deacetylases